Abstract
Introduction
Ischemic cardioplegic arrest and reperfusion as performed for cardiac transplantation and during most cardiopulmonary bypass protocols can result in decreased Ž .w x myocardial contractility stunning 1-3 . Strategies aimed at ameliorating postischemic myocardial injury include the improvement of cardioplegic solutions as well as modifications of the reperfusion protocol, such as warm cardioplegic blood reperfusion, or the use of agents directed at improving substrate metabolism, scavenging free O radi- A novel strategy embraces the use of 2,3 butanedione Ž . monoxime BDM as a protective additive during ischemia w x or cardioplegic arrest 4-6 as well as during reperfusion w x 7-9 . BDM is an effective negative inotropic and vasodilating agent, believed to decrease the sensitivity of contractile proteins to Ca 2q , or to directly inhibit actin-myosin w x crossbridge cycling 10-15 . BDM also considerably improves the myocardial O balance, by reducing myocardial 2 O demand and simultaneously increasing O delivery 2 2 w x 9,16,17 .
In a previous study we demonstrated that initial reperfusion with BDM for 5 min was more effective than initial Ž . hyperkalemic reperfusion in improving left ventricular LV Time for primary review 29 days.
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( )function in isolated Langendorff perfused guinea pig hearts w x 9 . BDM reperfusion also allowed for a faster return to regular electric activity, i.e. to sinus rhythm than hyperkalemic reperfusion. However, the improvement of LV function by BDM over hyperkalemic reperfusion in our experimental model was only marginal. A study by Schluter et al. indicates that 5 min of BDM application during initial reperfusion may be too short to elicit the maximum w x beneficial effect of BDM 8 . In an isolated heart model of the oxygen paradox, BDM suppressed LDH and CK release during re-oxygenation after 60 min of hypoxic perfusion, but had to be applied for up to 40 min to avoid a w x rebound of tissue damage after drug washout 8 . However, the biochemical and structural alterations of oxygen paradox induced tissue damage may differ considerably from the injury induced by cardioplegic arrest and reperfusion.
We, therefore, tested the hypothesis that after cardioplegic arrest initial reperfusion with BDM for 20 or 40 min is superior to only 5 min initial BDM reperfusion in reducing reperfusion damage, and such improving the recovery of myocardial function and maintaining cellular integrity. If that were the case, contraction uncoupling by BDM or equivalent drugs during early reperfusion might prove superior to the established protocols of warm cardioplegic reperfusion in reducing reperfusion damage of the heart after cardioplegic arrest.
Materials and methods
Following Animal Studies Committee approval, guinea Ž pigs 250-350 g., Charles River-Savo, Kisslegg, Ger-. many were injected intraperitoneally with 20 mg of ketamine and 1000 units of heparin, and were decapitated when unresponsive to noxious stimuli. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health Ž . NIH Publication No. 85-23, revised 1985 . Our methods w x have been published in detail 3,9,18 . After thoracotomy, the aorta was cannulated distal to the aortic valve and the venae cavae and pulmonary artery were cut. Each heart was immediately perfused through the aortic canula and excised. All hearts were perfused at a controlled perfusion pressure of 55 mmHg, measured at the aortic root. The perfusate, a modified Krebs-Ringer solution, was filtered Ž in-line 5 mm pore size; Minisart, Sartorius, Gottingen, . Ž . cardiac efficacy in utilizing consumed oxygen were calcuw x lated according to standard formulae 9 .
All directly measured electronic signals were displayed Ž . on a six-channel recorder Recomed 330-P, Hellige , and stored on a personal computer via a 16 channel AD-con-Ž . verter ME 26, Meilhaus Electronic, Puchheim, Germany for offline analysis.
Protocol and statistical analysis
Following completion of the preparation and a 30 min period of stabilization, baseline values of all measured variables were obtained and cardioplegic arrest was in-Ž duced by 20 ml of St. Thomas Hospital II solution 55
. mmHg, 378C . The hearts remained unperfused and submerged in the cardioplegic solution at 378C for 50 min. On reperfusion hearts were divided into four groups: Control Ž . hearts C, n s 8 were immediately reperfused with normal Krebs solution. In the study groups reperfusion was initiated with 20 mM BDM in Krebs solution for either 5 Ž . Ž . min BDM-5, n s 8 , 20 min BDM-20, n s 8 , or 40 min Ž . BDM-40, n s 8 before the perfusate was switched to normal Krebs. The LV-balloon remained inflated during cardioplegic arrest and initial reperfusion to record the effect of contracture, but balloon volume was adjusted to yield again 5 mmHg end-diastolic pressure after 10 min of perfusion with normal Krebs. At this time all hearts were Ž . also bolus infused with lidocaine 0.05 ml of 1% to convert any hearts not already in sinus rhythm. Coronary flow was measured at baseline, at the peak of reactive hyperemic flow, i.e. at 1 min of reperfusion, at the end of BDM perfusion, and at 5, 10, 15, and 30 min of reperfusion with normal Krebs. Postischemic recovery of all other variables was determined after 30 min of reperfusion. At ( )the end of the experiments hearts were fixated for electron microscopy by perfusion with Karnovsky solution and a tissue sample from the LV anterior free wall was excised for further processing.
All data are expressed as means " standard error of the mean. After testing for normal distribution of data, statistical differences among groups were obtained by student t-test, and for within group comparisons by paired t-test. p-Values were corrected for multiple comparisons accord-Ž . ing to Bonfferoni-Holm as appropriate. Differences were considered significant at p -0.05.
Results

Heart rate
Initial heart rate was not different among groups. No significant changes in heart rate occurred after 30 min reperfusion or among the experimental groups.
LV systolic and diastolic function
Ž . Left ventricular developed pressure LVDP was significantly depressed in all groups following cardioplegic arrest and reperfusion. However, in hearts initially reperfused with BDM, LVDP recovered faster and to a better During cardioplegic arrest and initial reperfusion LV diastolic pressure at constant balloon volume was monitored as an indicator of myocardial contracture. In all hearts balloon pressure increased similarly during cardio-Ž . plegic arrest Fig. 2 . With the onset of reperfusion diastolic balloon pressure rapidly increased even further and reached its peak after about 5 min. The presence of BDM in the reperfusate significantly attenuated this increase in all study groups. However, a sustained effect even after washout of the drug was only obtained after 20 or 40 min Ž . of BDM perfusion Fig. 2 
Coronary flow and O consumption 2
In all groups, coronary flow increased by 25 to 30% over preischemic baseline during reactive hyperemic reflow within the first min of reperfusion. Within 5 min of Ž . reperfusion control group or within 5 min of BDM Ž . washout treatment groups , coronary flow decreased in all groups to about 80 to 90% of baseline and remained at this Ž . level until the end of the reperfusion period Fig. 3 .
The vasodilatory action of BDM during initial reperfusion is reflected by the markedly decreased oxygen extraction at the end of the 5, 20 and 40 min of initial BDM Ž . perfusion for all oxygen data: see Table 1 . After BDM washout, oxygen extraction returned to preischemic baseline values and was not different among groups at the end of reperfusion. Oxygen demand was depressed during BDM perfusion by about 50%. Following washout of BDM, oxygen consumption increased, but remained significantly reduced in comparison to preischemic baseline only in control and BDM-40 hearts. Cardioplegic arrest and reperfusion decreased the efficiency of oxygen utilization similarly in all groups.
Electron microscopy
Control hearts, fixated for electron microscopy after 50 min cardioplegia and 30 min reperfusion displayed severe hypercontracture as indicated by the shortening of sarcomers and the wide and irregular Z-lines. Mitochondria were drastically swollen, the matrix widely cleared and only few Ž . intact cristae visible Fig. 4 . BDM-5 and BDM-40 hearts showed slight improvement of ultrastructural damage in comparison to control hearts, with moderate contracture and less mitochondrial edema. In BDM-20 hearts, contrac- Fig. 5 . Electron microscopy graph of a heart from the BDM-20 group, i.e. after 50 min of cardioplegic arrest in STH at 378C, and 20 min initial reperfusion with BDM followed by 30 min perfusion with normal Krebs. Only discreet signs of reperfusion damage are visible. The sarcomeres are contracted normally, without indication of hypercontracture. Z-lines are narrow and regularly shaped. Slight mitochondrial edema can be detected but cristae are widely preserved. Scale bar: 0.6 mm. 
Discussion
The most important findings of this study on reperfusion damage after cardioplegic arrest in isolated perfused Ž . guinea pig hearts are: 1 20 mM BDM added to the perfusate during reperfusion considerably reduced reperfusion contracture, improved recovery of postischemic myocardial function and attenuated ultrastructural damage; Ž . and 2 the optimal beneficial effect was achieved with 20 min as compared to only 5 min or the longer period of 40 min BDM perfusion.
The putative mechanism of the BDM effect in our study can be derived from the pathophysiology of reperfusion damage in the heart and the pharmacology of BDM. During ischemic cardioplegic arrest, cardiac myocytes are depleted of energy and Ca 2q accumulates in the cytosol. The increased intracellular Ca 2q concentration activates the contractile apparatus to induce contracture, but this effect is limited by the finite amount of Ca 2q present in the tissue and the lack of energy necessary for actin-myosin interaction. With the onset of reperfusion, extracellular Ca 2q is restored allowing for further Ca 2q influx while elimination of Ca 2q from the cytosol is inadequate. Simultaneously, rapid resumption of ATP synthesis provides sufficient energy for Ca 2q mediated actin myosin interaction, resulting in hypercontracture which may structurally damage cardiac myocytes by disrupting myofibrils, the cytoskeleton, and the sarcolemm.
BDM uncouples muscle contraction from excitation and the cytosolic Ca 2q concentration by decreasing the Ca 2q w x sensitivity of contractile proteins 10-13 , or by directly w x affecting actin-myosin crossbridge kinetics 14,15 . In con-Ž centrations above 5 to 10 mM 20 mM in the present . In the present study contracture was estimated by recording diastolic balloon pressure at a constant volume during cardioplegia and early reperfusion. In all groups balloon pressure increased only moderately during cardioplegia, indicating that contracture was sufficiently inhibited either by the lack of energy during ischemic arrest, by the protective properties of the St. Thomas Hospital II solution, or by a combination of both mechanisms. With the onset of reperfusion and washout of the cardioplegic solution, however, balloon pressure rapidly and markedly increased in the control hearts resulting in the typical and damaging hypercontracture during early reperfusion. As expected, the presence of BDM in the reperfusate attenuated this increase in balloon pressure. However, 5 min of BDM perfusion were insufficient to protect the heart from hypercontracture also after washout of the drug, while this goal was achieved after 20 and 40 min of BDM perfusion Ž . Fig. 2 .
In addition, BDM improves the myocardial O balance 2 Ž during initial reperfusion by reducing O demand at-2 . tenuated contracture, negative inotropy and dilating the w xŽ coronary vasculature 16,22 as indicated by decreased . oxygen extraction at unchanged flow in the present study . Because these effects, which markedly enhanced the myocardial O balance, were abolished with the onset of 2 BDM washout, the assumed protection through both, the improved O delivery to demand ratio and the increased 2 perfusion rate acted only while BDM was present and may thus also depend on the duration of BDM perfusion.
Our hypothesis that BDM improved functional recovery of the hearts by attenuating hypercontracture induced cellular damage during initial reperfusion after cardioplegic arrest is supported by the electron microscopy studies: control hearts show severe ultrastructural damage including markedly shortened sarcomers with widened and fuzzy Z-lines, indicating contracture. The mitochondria are swollen, the mitochondrial matrix is severely cleared, and most cristae are fragmentated. Amorphous densities, which would indicate irreversible ischemic injury in cardiac mitow x chondria 23 , were, however, not observed. These alterations were only slightly attenuated in BDM-5 and BDM-40 hearts, while sarcomeric and mitochondrial damage was markedly reduced only in hearts from the BDM-20 group, which also rendered the best functional recovery.
The reason for the partial loss of BDM mediated cardiac protection by increasing the duration of the initial BDM reperfusion from 20 to 40 min is not quite clear. However, longtime perfusion of non beating hearts has been demonstrated to increase tissue edema and to deteriow x rate cardiac function 24 . Also, BDM may exert a directly damaging effect on cell membranes and intracellular structures, e.g. through its phosphatase like enzymatic activity w x 25 . Possibly such toxic effects outweigh the protective actions when the application time exceeds a certain limit Ž . between 20 and 40 min in our study .
Critique of the methods
Following preliminary experiments, the duration of cardioplegic arrest was set at 50 min to achieve pronounced depression of post-ischemic function as to allow for monitoring of treatment effects. Also, a reperfusion period in control hearts and a BDM washout period in treated hearts of 30 min each were selected, because no further recovery of myocardial function was observed beyond this time. Thus differential total periods of reperfusion among groups did not influence the data on recovery of myocardial function. We also preferred to adjust end-diastolic balloon ( )pressure to 5 mmHg in all hearts after reperfusion, because control experiments demonstrated that systolic developed pressure was maximal in our heart preparation at this preload in control as well as post-ischemic hearts.
In conclusion, our data show that addition of 20 mM BDM to a normokalemic perfusate during initial reperfusion after cardioplegic ischemic arrest has the potential to attenuate hypercontracture, to markedly reduce ultrastructural myocardial damage, and to improve functional recovery of the heart. However, the optimal duration of such high dose BDM perfusion must be carefully evaluated. In our guinea pig isolated heart preparation 20 min of initial BDM reperfusion were clearly superior to either 5 min or 40 min of treatment. Thus, contraction uncoupling during initial reperfusion by BDM or similarly acting drugs may prove a viable and possibly superior alternative to warm cardioplegic reperfusion in patients undergoing open heart surgery.
